Cellular gene expression profiles in rhesus macaques challenged mucosally with a pathogenic R5 tropic simian human immunodeficiency virus isolate

Viral Immunology

Volumn 21, Issue 4, 2008, Pages 411-423

  Chung, Hye Kyung ^a   Pise Masison, Cynthia A ^b   Radonovich, Michael F ^b   Brady, John ^b   Lee, Jae K ^c   Cheon, Soo Young ^c   Markham, Phillip ^a   Cristillo, Anthony ^a   Pal, Ranajit ^a  

^a ADVANCED BIOSCIENCE LABORATORIES INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CD4 ANTIGEN; NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; CD4+ T LYMPHOCYTE; CELL COUNT; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; INOCULATION; MACACA; NONHUMAN; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIMATE; SIMIAN VIRUS; TROPICS; VIREMIA; VIRUS ISOLATION;

ANIMALS; ANTIBODIES, VIRAL; CD4 LYMPHOCYTE COUNT; GENE EXPRESSION PROFILING; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MACACA MULATTA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIREMIA;

ANIMALIA; MACACA MULATTA; PRIMATES; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 58149214260     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2008.0076     Document Type: Article

References (34)

1. Abel K, Alegria-Hartman MJ, Rothaeusler K, Marthas M, and Miller CJ: The relationship between simian immunodeficiency virus RNA levels and the mRNA levels of alpha/ beta interferons (IFN-alpha/beta) and IFN-alpha/beta-inducible Mx in lymphoid tissues of rhesus macaques during acute and chronic infection. J Virol 2002;76:8433-8445.
2. Abel K, Rocke DM, Chohan B, Fritts L, and Miller CJ: Temporal and anatomic relationship between virus replication and cytokine gene expression after vaginal simian immunodeficiency virus infection. J Virol 2005;79:12164-12172.
3. Bolstad BM, Irizarry RA, Astrand M, and Speed TP: A comparison of normalization methods for high-density oligonucleotide array data based on variance and bias. Bioinformatics 2003;19:185-193.
4. Bosinger SE, Hosiawa KA, Cameron MJ, et al.: Gene expression profiling of host response in models of acute HIV infection. J Immunol 2004;173:6858-6863.
5. + T cells in viremic versus aviremic HIV-infected individuals. Proc Natl Acad Sci USA 2003;100:1908-1913.
6. Donato R: S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 2001;33:637-668.
7. Giri MS, Nebozhyn M, Showe L, and Montaner LJ: Microarray data on gene modulation by HIV-1 in immune cells: 2000-2006. J Leukocyte Biol 2006;80:1031-1043.
8. Guignard F, Mauel J, and Markert M: Identification and characterization of a novel human neutrophil protein related to the S100 family. Biochem J 1995;309:395-401.
9. Haigwood NL: Predictive value of primate models for AIDS. AIDS Rev 2004;6:187-198.
10. Harouse JM, Gettie A, Eshetu T, et al.: Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV (SF162P3). J Virol 2001;75:1990-1995.
11. Heizmann CW, Fritz G, and Schafer BW: S100 proteins: structure, functions and pathology. Front Biosci 2002;7:1356-1368.
12. Hofmann MA, Drury S, Fu C, et al.: RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999;97:889-901.
13. Hsu M, Buckner C, Harouse J, Gettie A, Blanchard J, Robinson JE, and Cheng-Mayer C: Antigenic variations in the CD4 induced sites of the CCR5-tropic, pathogenic SHIVsf162p3 gp120 variants. J Med Primatol 2003;32:211-217.
14. Hsu M, Harouse JM, Gettie A, Buckner C, Blanchard J, and Cheng-Mayer C: Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIV (SF162P3) maps to envelope gp120. J Virol 2003;77:989-998.
15. Hsu M, Ho SH, Balfe P, Gettie A, Harouse J, Blanchard J, and Cheng-Mayer C: A CCR5-tropic simian-HIV molecular clone capable of inducing AIDS in rhesus macaques. J Acquir Immune Defic Syndr 2005;40:383-387.
16. Jain N, Thatte J, Braciale T, Ley K, O'Connell M, and Lee JK: Local-pooled-error test for identifying differentially expressed genes with a small number of replicated microarrays. Bioinformatics 2003;19:1945-1951.
17. Knapp LA, Lehmann E, Piekarczyk MS, Urvater JA, and Watkins DI: A high frequency of Mamu-A*01 in the rhesus macaque detected by polymerase chain reaction with sequence-specific primers and direct sequencing. Tissue Antigens 1997;50:657-661.
18. Krishnan V, and Zeichner SL: Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency. J Virol 2004;78:9458-9473.
19. + central memory T cells and survival in vaccinated SIV-challenged monkeys. Science 2006;312:1530-1533.
20. Muhl T, Krawczak M, Ten Haaft P, Hunsmann G, and Sauermann U: MHC class I alleles influence set-point viral load and survival time in simian immunodeficiency virus-infected rhesus monkeys. J Immunol 2002;169:3438-3446.
21. Pal R, Venzon D, Letvin NL, et al.: ALVAC-SIV-gag-pol-envbased vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency. J Virol 2002;76:292-302.
22. + T-cell loss and reduces both systemic and mucosal simian-human immunodeficiency virus SHIVKU2 RNA levels. J Virol 2006;80:3732-3742.
23. Pise-Masison CA, Radonovich M, Mahieux R, et al.: Transcription profile of cells infected with human T-cell leukemia virus type I compared with activated lymphocytes. Cancer Res 2002;62:3562-3571.
24. + T-cell repertoires in long-term nonprogressors and its role in the control of viral load and disease activity. Hum Immunol 2001;62:561-576.
25. Romano JW, Shurtliff RN, Dobratz E, Gibson A, Hickman K, Markham PD, and Pal R: Quantitative evaluation of simian immunodeficiency virus infection using NASBA technology. J Virol Methods 2000;86:61-70.
26. + T lymphocytes. J Immunol 2002;169:3307-3313.
27. Sankaran S, Guadalupe M, Reay E, George MD, Flamm J, Prindiville T, and Dandekar S: Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors. Proc Natl Acad Sci USA 2005;102:9860-9865.
28. Schafer BW, and Heizmann CW: The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem Sci 1996;21:134-140.
29. + lymphocytes. Science 1999;283:857-860.
30. + central memory T cells in protection from simian AIDS. J Immunol 2005;175:3502-3507.
31. Vahey MT, Nau ME, Taubman M, Yalley-Ogunro J, Silvera P, and Lewis MG: Patterns of gene expression in peripheral blood mononuclear cells of rhesus macaques infected with SIVmac251 and exhibiting differential rates of disease progression. AIDS Res Hum Retroviruses 2003;19:369-387.
32. van 't Wout AB, Lehrman GK, Mikheeva SA, et al.: Cellular gene expression upon human immunodeficiency virus type 1 infection of CD4 (+)-T-cell lines. J Virol 2003;77:1392-1402.
33. + lymphocyte phenotype and cytokine production in long-term non-progressor and in progressor patients with HIV-1 infection. Clin Exp Immunol 1996;105:220-224.
34. Zhang YJ, Fracasso C, Fiore JR, Bjorndal A, Angarano G, Gringeri A, and Fenyo EM: Augmented serum neutralizing activity against primary human immunodeficiency virus type 1 (HIV-1) isolates in two groups of HIV-1-infected long-term nonprogressors. J Infect Dis 1997;176:1180-1187.